correspondence: CD23 expression in plasma cell leukaemia

Plasma cell leukaemia relapsing in the dermis.

Primary plasma cell leukaemia--a case report.

Plasma cell leukemia is a rare disease entity where the number of clonal plasma cells in the peripheral blood exceeds 2X10 9 /l or 20% of the total leukocyte count. This plasma cell leukemia can be primary which is arising denovo or secondary as in the course of plasma cell myeloma. A 40 year old female who came to the outpatient department with complaints of low back pain for 3 months and had ...

Plasma cell leukaemia: a management conundrum

Primary plasma cell leukaemia in a young transplant eligible patient brings forth a number of perplexing questions and many remain unanswered. There are good data to suggest the superiority of novel agents over conventional chemotherapy regimens, however choosing between autologous and allogeneic haematopoietic stem cell transplant in first remission remains a therapeutic conundrum. We report a...

IgE myeloma associated with plasma cell leukaemia.

A patient presented with plasma cell leukaemia and was found to have an IgE secreting multiple myeloma. IgE myeloma is very rare with only 18 cases recorded. However, this case is the fifth recorded of IgE myeloma associated with plasma cell leukaemia. Since plasma cell leukaemia only occurs in 1.6% of all cases of myeloma, it seems certain that this is a significant association.

Case Study Primary Plasma Cell Leukaemia

Plasma cell leukemia (PCL) is a rare form of malignant plasma cell dyscrasia. It can occur as a primary form without prior evidence of multiple myeloma or as a secondary form which is a terminal event in multiple myeloma. It is characterised by a proliferation of plasma cells in blood and the bone marrow. The outcome of plasma cell leukemia is poor with conventional therapy. Here we illustrate ...